Medical devices; general and plastic surgery devices; classification of the absorbable lung biopsy plug. Final order [0.03%]
医疗器械；一般和整形外科器械；可吸收肺活检插件的分类。最终命令
Food and Drug Administration, HHS
Food and Drug Administration
The Food and Drug Administration (FDA) is classifying the absorbable lung biopsy plug into class II (special controls). The special controls that will apply to the device are identified in this order, and will be part of the codified langua...
Standards to prevent, detect, and respond to sexual abuse and assault in confinement facilities. Final rule [0.03%]
关于羁押场所预防、发现和应对性侵犯的条例（最终条例）
Department of Homeland Security
Department of Homeland Security
The Department of Homeland Security (DHS) is issuing regulations setting standards to prevent, detect, and respond to sexual abuse and assault in DHS confinement facilities.
Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order [0.03%]
关于管制物质品种安排：暂时将10种合成卡西酮类物质列入一表最终命令
Drug Enforcement Administration, Department of Justice
Drug Enforcement Administration
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule 10 synthetic cathinones into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances A...
Medicare determinations and income-related monthly adjustment amounts to Medicare Part B premiums; conforming changes to regulations. Final rule [0.03%]
关于MEDICARE决定和与收入相关的月调整额以确定MEDICARE部分B保费；法规符合性修改最终规则
Social Security Administration
Social Security Administration
This final rule adopts, without change, the interim final rule with request for comments we published in the Federal Register on September 18, 2013. The interim final rule modified our rules regarding Medicare Part B income-related monthly ...
Extension of expiration dates for several body system listings. Final rule [0.03%]
若干身体系统条目的有效期延长最终规则
Social Security Administration
Social Security Administration
We are extending the expiration dates of the following body systems in the Listing of Impairments (listings) in our regulations: Growth Impairment, Musculoskeletal System, Respiratory System, Cardiovascular System, Digestive System, Skin Di...
Ninety-day waiting period limitation and technical amendments to certain health coverage requirements under the Affordable Care Act. Final rule [0.03%]
关于《平价医疗法案》下某些健康保险要求的90天等待期限制和技术修正最终规则
Internal Revenue Service, Department of the Treasury;Employee Benefits Security Administration, Department of Labor;Centers for Medicare & Medicaid Services et al.
Internal Revenue Service et al.
These final regulations implement the 90-day waiting period limitation under section 2708 of the Public Health Service Act, as added by the Patient Protection and Affordable Care Act (Affordable Care Act), as amended, and incorporated into ...
International Conference on Harmonisation; E2B(R3) Electronic Transmission of Individual Case Safety Reports; Data Elements and Message Specification; Appendix on Backwards and Forwards Compatibility; availability. Notice [0.03%]
国际协调会议；个例安全报告电子传输E2B(R3)；数据元素和消息规范；兼容性附录；可获取性。通知
Food and Drug Administration, HHS
Food and Drug Administration
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "E2B(R3) Electronic Transmission of Individual Case Safety Reports (ICSRs): Implementation Guide--Data Elements and Message Specificat...
World Trade Center Health Program; amendments to list of WTC-related health conditions; cancer; revision. Interim final rule [0.03%]
关于修订世贸中心相关健康状况清单的暂行最终规则；癌症；修正案世界贸易中心健康计划
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
Centers for Disease Control and Prevention (CDC)
On September 12, 2012, the Administrator of the WTC Health Program (Administrator) published a final rule in the Federal Register adding certain types of cancer to the List of World Trade Center (WTC)-Related Health Conditions (List) in the...
Medical devices; neurological devices; classification of the neuropsychiatric interpretive electroencephalograph assessment aid. Final order [0.03%]
医疗器械；神经病学器械；神经精神病学脑电图解读辅助评估器械分类最终命令
Food and Drug Administration, HHS
Food and Drug Administration
The Food and Drug Administration (FDA) is classifying the neuropsychiatric interpretive electroencephalograph (EEG) assessment aid into class II (special controls). The Agency is classifying the device into class II (special controls) in or...
Food and Drug Administration, HHS
Food and Drug Administration
The Food and Drug Administration (FDA) is revising its postmarket medical device reporting regulation and making technical corrections. This final rule requires device manufacturers and importers to submit mandatory reports of individual me...